A Phase I/II Study of Polymerized Bovine Hemoglobin in Adult Patients with Sickle Cell Disease not in Crisis at the Time of Study
1997 · Journal of Investigative Medicine · 54 citations
https://doi.org/10.1177/108155899704500505
P
Pedro González
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
665
Citations
11
h-index
11
i10-index
Pedro González is an academic researcher from Pontificia Universidad Católica de Chile. The author has contributed to research in topics: Antimicrobial Resistance in Staphylococcus & Bacterial Identification and Susceptibility Testing & Streptococcal Infections and Treatments. The author has an h-index of 11, co-authored 55 publications.
ORCID: 0009-0001-0136-7571Papers by this author
worksReducing non-attendance in outpatient appointments: predictive model development, validation, and clinical assessment
2022 · BMC Health Services Research · 18 citations
https://doi.org/10.1186/s12913-022-07865-y
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
2021 · Infectious Diseases and Therapy · 13 citations
https://doi.org/10.1007/s40121-021-00402-0
Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials
2021 · Infectious Diseases and Therapy · 7 citations
https://doi.org/10.1007/s40121-021-00568-7
Dalbavancin utilization registry investigating value and effectiveness (DRIVE): Outcomes report on real-world use
2023 · Clinical Infection in Practice · 3 citations
https://doi.org/10.1016/j.clinpr.2023.100251
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat